The epidemiological profile of alcohol and other drug use in metropolitan China
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
There is evidence that alcohol, tobacco, and other drug use may be rising in China, but epidemiological studies that examine several drugs simultaneously and the transition from initial try to current use are limited. The present study provides an epidemiological profile of drug use in contemporary metropolitan China.
A multistage probability sampling method was used to select household-dwelling adults in Beijing and Shanghai. Standard face-to-face interviews with 5,201 participants were completed during 2002–2003.
An estimated 70–76% had used any type of drug: alcohol and tobacco were the most commonly used drugs (alcohol, 67%; tobacco, 39%). Regarding extra-medical use of internationally regulated drugs, sedatives and analgesics were most common and illegal drug use was rare. The majority of tobacco users used it recently (82.5%), especially young adults. Male–female differences were observed in lifetime tobacco use, but not for recent use. Concurrent use of alcohol and tobacco was very common.
Psychoactive drug use is common in metropolitan China. Public health policies and prevention initiatives may be needed to address associated problems that may increase following the country’s rapid socioeconomic change.
- The epidemiological profile of alcohol and other drug use in metropolitan China
International Journal of Public Health
Volume 55, Issue 6 , pp 645-653
- Cover Date
- Print ISSN
- Online ISSN
- SP Birkhäuser Verlag Basel
- Additional Links
- Substance use
- Industry Sectors
- Author Affiliations
- 1. Department of Epidemiology, Michigan State University, B601 West Fee Hall, East Lansing, MI, 48824, USA
- 4. Peking University Institute of Mental Health, Beijing, People’s Republic of China
- 2. Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China
- 3. Hong Kong Mood Disorders Center, The Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China
- 5. Department of Health Care Policy, Harvard Medical School, Boston, MA, USA